Literature for peptidase S01.017: kallikrein-related peptidase 5

(References are filtered for relevance to Mutation. To remove the filter click here. See explanation.)

2019
1. White,G.V., Edgar,E.V., Holmes,D.S., Lewell,X.Q., Liddle,J., Polyakova,O., Smith,K.J., Thorpe,J.H., Walker,A.L., Wang,Y., Young,R.J. and Hovnanian,A.
   Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome
   Bioorg Med Chem Lett29, 821-825. PubMed  Europe PubMed DOI  M  I
2017
2. Adamopoulos,P.G., Kontos,C.K. and Scorilas,A.
   Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing
   Sci Rep7, 17299-17299. PubMed  Europe PubMed DOI  M
2013
3. Lose,F., Batra,J., O'Mara,T., Fahey,P., Marquart,L., Eeles,R.A., Easton,D.F., Al Olama,A.A., Kote-Jarai,Z., Guy,M., Muir,K., Lophatananon,A., Rahman,A.A., Neal,D.E., Hamdy,F.C., Donovan,J.L., Chambers,S., Gardiner,R.A., Aitken,J.F., Yaxley,J., Alexander,K., Clements,J.A., Spurdle,A.B. and Kedda,M.A.
   Common variation in kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness
   Urol Oncol31, 635-643. PubMed  Europe PubMed DOI  M